In the coming years, the Internet of Things is expected to play a key role in improving global health, and Qualcomm (NASDAQ: QCOM) intends to be a leading player in that process. Qualcomm’s IoT efforts are working, and now it can add another “win” to its tally, after announcing a partnership with Ireland-based health technology giant Medtronic (NYSE: MDT) to jointly develop continuous glucose monitoring (CGM) systems for diabetes sufferers.